Bank of America’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.98B Buy
32,586,981
+17,527,686
+116% +$1.02B 0.14% 152
2025
Q4
$812M Sell
15,059,295
-1,829,010
-11% -$88M 0.06% 284
2025
Q3
$762M Sell
16,888,305
-1,010,399
-6% -$47.2M 0.05% 330
2025
Q2
$829M Sell
17,898,704
-3,298,318
-16% -$162M 0.06% 302
2025
Q1
$1.29B Buy
21,197,022
+1,259,161
+6% +$73.4M 0.1% 194
2024
Q4
$1.13B Buy
19,937,861
+1,819,326
+10% +$102M 0.09% 217
2024
Q3
$937M Sell
18,118,535
-35,177
-0.2% -$1.65M 0.08% 261
2024
Q2
$754M Sell
18,153,712
-2,733,429
-13% -$122M 0.07% 290
2024
Q1
$1.13B Buy
20,887,141
+164,532
+0.8% +$8.38M 0.1% 206
2023
Q4
$1.06B Sell
20,722,609
-7,443,316
-26% -$391M 0.11% 201
2023
Q3
$1.63B Sell
28,165,925
-936,229
-3% -$57.4M 0.18% 126
2023
Q2
$1.86B Sell
29,102,154
-9,451,754
-25% -$634M 0.2% 116
2023
Q1
$2.67B Sell
38,553,908
-1,572,152
-4% -$111M 0.27% 80
2022
Q4
$2.89B Sell
40,126,060
-5,061,691
-11% -$382M 0.33% 69
2022
Q3
$3.21B Sell
45,187,751
-1,447,739
-3% -$105M 0.38% 50
2022
Q2
$3.59B Buy
46,635,490
+18,403,031
+65% +$1.4B 0.41% 46
2022
Q1
$2.06B Buy
28,232,459
+984,711
+4% +$66.1M 0.2% 107
2021
Q4
$1.7B Sell
27,247,748
-2,302,367
-8% -$135M 0.17% 123
2021
Q3
$1.75B Buy
29,550,115
+942,625
+3% +$62.1M 0.18% 113
2021
Q2
$1.91B Sell
28,607,490
-4,486,011
-14% -$293M 0.2% 109
2021
Q1
$2.09B Buy
33,093,501
+780,091
+2% +$48.5M 0.23% 92
2020
Q4
$2B Sell
32,313,410
-575,454
-2% -$35.4M 0.26% 95
2020
Q3
$1.98B Buy
32,888,864
+1,154,893
+4% +$69.5M 0.27% 89
2020
Q2
$1.87B Buy
31,733,971
+1,035,666
+3% +$61.9M 0.28% 83
2020
Q1
$1.71B Buy
30,698,305
+2,688,319
+10% +$164M 0.31% 78
2019
Q4
$1.8B Buy
28,009,986
+14,590,752
+109% +$836M 0.26% 96
2019
Q3
$680M Buy
13,419,234
+1,503,545
+13% +$70.7M 0.1% 207
2019
Q2
$540M Sell
11,915,689
-673,493
-5% -$31.4M 0.08% 245
2019
Q1
$601M Buy
12,589,182
+1,957,489
+18% +$97.5M 0.09% 217
2018
Q4
$553M Sell
10,631,693
-516,788
-5% -$27.8M 0.1% 218
2018
Q3
$692M Buy
11,148,481
+233,967
+2% +$13.9M 0.11% 195
2018
Q2
$604M Sell
10,914,514
-988,112
-8% -$53.4M 0.1% 212
2018
Q1
$753M Buy
11,902,626
+814,481
+7% +$52.4M 0.13% 174
2017
Q4
$679M Sell
11,088,145
-445,084
-4% -$27.8M 0.11% 197
2017
Q3
$735M Buy
11,533,229
+590,951
+5% +$34.5M 0.12% 189
2017
Q2
$610M Sell
10,942,278
-649,525
-6% -$35.3M 0.12% 187
2017
Q1
$630M Sell
11,591,803
-631,212
-5% -$34.6M 0.13% 172
2016
Q4
$714M Sell
12,223,015
-2,332,385
-16% -$128M 0.15% 159
2016
Q3
$785M Buy
14,555,400
+619,766
+4% +$39.8M 0.17% 147
2016
Q2
$1.02B Buy
13,935,634
+142,156
+1% +$10M 0.24% 104
2016
Q1
$881M Sell
13,793,478
-4,341,604
-24% -$274M 0.21% 115
2015
Q4
$1.25B Buy
18,135,082
+791,083
+5% +$52.3M 0.3% 74
2015
Q3
$1.03B Buy
17,343,999
+8,370,920
+93% +$531M 0.26% 97
2015
Q2
$597M Sell
8,973,079
-16,269
-0.2% -$1.07M 0.19% 112
2015
Q1
$580M Sell
8,989,348
-436,535
-5% -$27.3M 0.2% 119
2014
Q4
$556M Sell
9,425,883
-167,751
-2% -$9.46M 0.2% 101
2014
Q3
$491M Sell
9,593,634
-1,142,653
-11% -$57.1M 0.16% 137
2014
Q2
$521M Sell
10,736,287
-3,223,473
-23% -$159M 0.17% 133
2014
Q1
$725M Sell
13,959,760
-234,250
-2% -$12.5M 0.27% 74
2013
Q4
$754M Sell
14,194,010
-573,237
-4% -$29.2M 0.27% 69
2013
Q3
$683M Sell
14,767,247
-1,803,701
-11% -$79.2M 0.27% 71
2013
Q2
$741M Buy
+16,570,948
New +$719M 0.31% 61

Other funds holding BMY

Bank of America's BMY Position: Q1 2026 in Review

Bank of America increased its Bristol-Myers Squibb (BMY) stake by 116% in Q1 2026, buying an estimated $1.02B and bringing the position to 32,586,981 shares worth $1.98B. The position accounts for 0.14% of the portfolio, ranked #152.

Bank of America first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.59B in Q2 2022. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Bank of America held 32,586,981 shares of Bristol-Myers Squibb worth $1.98B as of Q1 2026.
  • Bank of America bought 17,527,686 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.02B.
  • Bristol-Myers Squibb made up 0.14% of Bank of America's portfolio in Q1 2026, its #152 holding.
  • Bank of America first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's Bristol-Myers Squibb position peaked at $3.59B in Q2 2022.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.